Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,498 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recent advances in immunotherapy for cervical cancer.
Ogasawara A, Hasegawa K. Ogasawara A, et al. Among authors: hasegawa k. Int J Clin Oncol. 2025 Jan 31. doi: 10.1007/s10147-025-02699-0. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39888529 Review.
The first complete hand-rearing of two neonatal finless porpoises.
Kasamatsu M, Hasegawa K, Wakabayashi I, Furuta M, Inoue H, Iwano H. Kasamatsu M, et al. Among authors: hasegawa k. PLoS One. 2025 Jan 30;20(1):e0288891. doi: 10.1371/journal.pone.0288891. eCollection 2025. PLoS One. 2025. PMID: 39883650 Free PMC article.
Validation of a Pretransplant Risk Prediction Model for Early Allograft Dysfunction After Living-donor Liver Transplantation.
Li Z, Raptis D, Rammohan A, Gunasekaran V, Hong S, Chen IC, Kim J, Hervera Marquez KA, Hsu SC, Kirimker EO, Akamatsu N, Shaked O, Finotti M, Yeow M, Genedy L, Braun J, Yebyo H, Dutkowski P, Nadalin S, Boehnert MU, Polak WG, Bonney GK, Mathur A, Samstein B, Emond JC, Testa G, Olthoff KM, Rosen CB, Heimbach JK, Taner T, Wong TC, Lo CM, Hasegawa K, Balci D, Cattral M, Sapisochin G, Selzner N, Jeng LB, Joh JW, Chen CL, Suh KS, Rela M, Broering D, Clavien PA. Li Z, et al. Among authors: hasegawa k. Transplantation. 2025 Jan 28. doi: 10.1097/TP.0000000000005331. Online ahead of print. Transplantation. 2025. PMID: 39883022
Intraperitoneal chemotherapy is now back for ovarian cancer.
Fujiwara K, Nagao S, Tan D, Hasegawa K. Fujiwara K, et al. Among authors: hasegawa k. Int J Clin Oncol. 2025 Jan 29. doi: 10.1007/s10147-025-02700-w. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39875651 Review.
Risk factors for pancreatic cancer in individuals with intraductal papillary mucinous neoplasms and no high-risk stigmata during up to 5 years of surveillance: a prospective longitudinal cohort study.
Hamada T, Oyama H, Nevo D, Tange S, Takaoka S, Kawaguchi Y, Ishigaki K, Noguchi K, Saito T, Sato T, Suzuki T, Takahara N, Tanaka M, Hasegawa K, Ushiku T, Nakai Y, Petrov MS, Fujishiro M; TOP-CREATE Study Group. Hamada T, et al. Among authors: hasegawa k. Gut. 2025 Jan 27:gutjnl-2024-333259. doi: 10.1136/gutjnl-2024-333259. Online ahead of print. Gut. 2025. PMID: 39870394
[Guidelines for presymptomatic genetic testing for adult-onset hereditary neuromuscular diseases in Japan].
Shibata Y, Chang H, Nakamura K, Yamada S, Matsushima M, Saigoh K, Ishiura H, Sekijima Y, Maruyama H, Ikeuchi T, Hasegawa K, Aoki M, Katsuno M, Toda T, Yabe I; Committee on Medical Genetics, Japanese Society of Neurology. Shibata Y, et al. Among authors: hasegawa k. Rinsho Shinkeigaku. 2025 Jan 24. doi: 10.5692/clinicalneurol.cn-002049. Online ahead of print. Rinsho Shinkeigaku. 2025. PMID: 39864867 Japanese.
Pharmacokinetic and Exposure-Response Modeling Support Body Surface Area-Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.
Hayato S, Hamuro L, Shimizu T, Yonemori K, Nishio S, Yunokawa M, Yoshida T, Nishio M, Matsumoto K, Takehara K, Hasegawa K, Kozuki T, Hirashima Y, Kato H, Miura T, Nomoto M, Zhao Y, Zhu L, Yasuda S. Hayato S, et al. Among authors: hasegawa k. J Clin Pharmacol. 2025 Jan 24. doi: 10.1002/jcph.6187. Online ahead of print. J Clin Pharmacol. 2025. PMID: 39853764
Frequency of anti-IgLON5 disease in patients with a typical clinical presentation of progressive supranuclear palsy/corticobasal syndrome.
Ono Y, Takigawa H, Takekoshi A, Yoshikura N, Aiba I, Hanajima R, Kowa H, Kanazawa M, Tokuda T, Tokumaru AM, Morita M, Hasegawa K, Nakashima K, Ikeuchi T, Kimura A, Shimohata T; JALPAC Study Group. Ono Y, et al. Among authors: hasegawa k. Parkinsonism Relat Disord. 2025 Jan 15:107289. doi: 10.1016/j.parkreldis.2025.107289. Online ahead of print. Parkinsonism Relat Disord. 2025. PMID: 39843325
Identification of factors related to functional prognoses in craniopharyngiomas.
Umeda T, Otani Y, Fujii K, Ishida J, Hirano S, Suruga Y, Kemmotsu N, Imoto R, Kegoya Y, Mizuta R, Inoue Y, Hokama M, Makihara S, Hasegawa K, Inagaki K, Otsuka F, Yasuhara T, Tanaka S. Umeda T, et al. Among authors: hasegawa k. J Neurooncol. 2025 Jan 22. doi: 10.1007/s11060-024-04925-7. Online ahead of print. J Neurooncol. 2025. PMID: 39841323
4,498 results